baber/WOPTO huggingface dataset:
Patent PT-940234-E (PT)
Inventor: MIOTTO SERGIO
IPC: B28B3/02
Filed: 1999-02-18
Abstract: A machine for forming ceramic tiles by pressing in a mould, comprising a fixed lower base acting as a reaction base during pressing and having a horizontal bearing surface, a vertically movable member, and an upper die carried by the movable member to define the upper surface of the mould forming cavity, includes a flat lower element of sufficiently compression-resistant material resting on the bearing surface and movable on it to act as the lower surface of the mould cavity, a mould die plate positioned above said flat element to define the side walls of the mould cavity and movable vertically between a lower position in contact with the flat lower element and an upper position in which it is raised from the flat element to enable the formed tiles to pass below it, after each pressing operation said flat lower element being moved horizontally in combination with the raising of the die plate, to remove the formed tile. <IMAGE>
Patent PT-951908-E (PT)
Inventor: CRAIG MAYTOM MURRAY
IPC: A61P15/00
Filed: 1999-02-15
Abstract: A class of cGMP PDE inhibitors, including sidenafil and pharmaceutically acceptable salts thereof, which can be used to treat sexual dysfunction in male and female animals, especially humans, with a spinal cord injury. The invention can be used to treat sexual dysfunction in male animals that exhibit essentially no residual penile function.
Patent PT-1075445-E (PT)
Inventor: REIST WALTER
IPC: B65H29/66
Filed: 1999-02-16
Abstract: In each case at least two objects arriving in a lamellar flow (14) are grasped from the side by a conveyor clamp (22) and conveyed further while maintaining their mutual position. The at least two objects forming a section are held by a single conveyor clamp in a clamping area (30) where the objects (14) overlap.
Patent PT-1084403-E (PT)
Inventor: ANGELIS LUCIO DE
IPC: G01N33/24
Filed: 1999-02-18
Abstract: A process is described, and also the system for its embodiment, for the determination of pollution by MTBE in the soil and in the overlying atmosphere. An example is described relating to the monitoring of underground fuel tanks for autotraction containing an oxygenated additive.
Patent SG-59392-G (SG)
Title: Detergent compositions
IPC: C11D3/37
Filed: 1992-06-04
Abstract: Granular detergent compositions having an effective suds controlling agent comprising a suds-controlling silicone material which is substantially removed from contact with the surfactant component or alkaline component of the composition by incorporation in, e.g., a polyethylene glycol carrier, with preferably a small amount of fatty acid, in an irregularly shaped particle having a minimum dimension of at least about 0.05 cm. and being substantially free of water soluble inorganic salts.
Patent SG-95287-G (SG)
Title: Thieno(3,2-c)pyridine derivatives,process for their preparation and their therapeutical use
IPC: C07D495/04
Filed: 1987-10-29
Abstract: This invention relates to new thieno [3,2-c] pyridine derivatives having the formula:    <IMAGE>  (I)  in which: Y represents the OH group or an OR group in which R is a straight or branched lower alkyl radical, or Y represents a group   <IMAGE>  in which R1 and R2 are each independently of each other, hydrogen or a straight or branched lower alkyl group; or R1 and R2 form together and with the nitrogen atom to which they are attached a heterocycle which may include a second heteroatom such as oxygen or nitrogen, wherein the latter may be substituted by a lower alkyl or benzyl radical which may be substituted; and X represents hydrogen, a halogen or a lower alkyl radical; and their addition salts with pharmaceutically acceptable mineral or organic acids if Y represents the group OR or    <IMAGE> or with mineral bases if Y represents OH, as well as the two enantiomers or their mixture. The invention also relates to the preparation process of new thieno [3,2-c] pyridine derivatives and to their therapeutic application as blood-platelet aggregation inhibiting agents and antithrombotics.
Patent SG-41976-G (SG)
Title: Watch case and watch provided with such a case
Inventor: MUELLER JACQUES
IPC: G04B37/11
Filed: 1990-01-05
Abstract: Wrist-watch case whose middle part (12) carries horns (17) and whose back (10) is equipped with a central rib (26) and with radial ribs (28a, 28b, 28c). 
<??>The peripheral end of a radial rib (28a, 28c) is located in the extension of each horn (17). 
<IMAGE>
Patent IE-33944-L (IE)
Title: Treatment of mastitis
IPC: A61K38/00
Filed: 1970-01-16
Abstract: 1297011 Mastitis immuno-globulins AGRICURA LABORATORIA Ltd 19 Jan 1970 [17 Jan 1969 13 March 1969] 2582/70 Heading A5B Mastitis immuno-globulin and polyvalent mastitis immunoglobulin are prepared by a process which comprises (a) mixing blood, which is obtained from one or more cows (where the word cows may include sheep ewes and she goats) which are suffering from chronic mastitis and/or are in a hyperimmune state with respect to mastitis, with an anticoagulant and an antihaemolytic; (b) removing the blood cells by centrifuging to form a plasma; (c) converting the plasma to a gel by adding calcium chloride solution; (d) straining the gel to produce a serum; (e) precipitating the mastitis immuno-globulin from the serum by adding ammonium sulphate solution; (f) filtering off the mastitis immuno-globulin and removing ammonium sulphate by dialysis; (g) removing large molecule protein impurities by centrifuging. The globulins may be used in the form of compositions containing a preservative such as phenol and/or one or more antibiotics selected from penicillin G. semisynthetic penicillions, streptomycin, dihydrostreptomycin or the sulphate thereof, F furazolidone, erythromycin, novobiocin, neomycin, bacitracin and chloramphenicol. The product may be freeze dried.
[GB1297011A]
Patent IE-870230-L (IE)
Title: Substituted pyrrolidinones.
IPC: C07D207/26
Filed: 1987-01-29
Abstract: Substituted pyrrolidin-2-ones of the formula   <IMAGE> (I)  wherein R1 represents a phenyl or naphthyl radical that is unsubstituted or substituted by lower alkyl, lower alkloxy, halogen and/or trifluoromethyl, X1 represents lower alkylidene, X2 represents methylene, ethylene or oxoethylene and R2 represents hydrogen, lower alkyl or a radical of the formula   <IMAGE> (Ia)   wherein X4 represents lower alkylidene and R3 represents hydrogen or a phenyl or a phenyl naphthyl radical that is unsubstituted by lower alkyl, lower alkoxy, halogen and/or trifluoromethyl, and their pharmaceutically acceptable salts, have nootropic properties and can be used as nootropic active ingredients in medicaments. They are prepared, for example, by condensing with one another compounds of the formulae <IMAGE> (II)  and  <IMAGE> (III)   wherein Z1 represents a group of the formula -X1-(=O)-Z3 (IIa) and Z2 represents hydrogen, or Z1 represents hydrogen and Z2 represents a group of the formula -C(=O) -X1-Z4 (IIIa), wherein each of Z3 and Z4 represents a removable radical and R2' represnts a radical R2 or amino-protecting group, or their salts, and removing an amino-protecting R2' which may be present.
Patent IE-36157-L (IE)
Title: Data-handling apparatus
IPC: G06F19/00
Filed: 1972-03-13
Abstract: 1380925 Electric analogue calculating QELEQ Ltd 10 March 1972 [18 March 1971] 7247/71 Heading G4G An analogue data handling apparatus receives as an input a set of values representing different variables, this set is compared with another set of values representing the same variables and which are known and stored in the apparatus and an output signal is derived which is indicative of the degree of correspondence between the two sets. In Fig. 2, an interface circuit 1, a difference circuit 3, a modulus circuit 6, a comparator 8 and a multiplier 11 are provided for each variable and the output of this chain is a signal inversely proportional to the deviation of the value of the variable in the input set from its value in the stored set in store 34 multiplied by a weighting factor in accordance with the significance of the variable in the set. These outputs for all the variables are summed at 14 and passed through a logarithmic stage 16 to give the output indicative of the degree of correspondence. The inputs can be sequentally compared with a plurality of stored sets.
[GB1380925A]
Patent IE-32334-L (IE)
Title: Glyceryl esters
IPC: C07D405/06
Filed: 1968-04-09
Abstract: 1,220,468. α-Glyceryl esters. SCHERICO Ltd. 5 April, 1968 [10 April, 1967 (2)], No. 16477/68. Heading C2C. Novel compounds of formula I and cyclic acetals and ketals and salts thereof wherein A is N or CH, R is H or CH 3 , R<SP>1</SP> is alkyl, alkoxy, halogen CF 3 or NO 2 , R<SP>2</SP> and R, are each H, NO 2 , CF 3 , halogen or alkyl are prepared by condensation by known methods of a compound of formula Y.CH 2 X<SP>1</SP> with a compound of formula wherein X<SP>1</SP> is an α,#-dihydroxyethyl group or a cyclic acetal or ketal thereof or is a vinyl or epoxyethyl group and Y and Z are groups capable of condensing during the reaction to leave a bridge of formula between the groups -CH 2 X<SP>1</SP> and that of formula and, where X<SP>1</SP> is vinyl or epoxyethyl, converting the product by known methods of oxidation and/or hydrolysis to a #,γ-dihydroxypropyl ester. The preferred exemplified method involves transesteriflcation of a compound of Formula VI wherein B is an electron withdrawing group, e.g. cyano, carbamoyl, acyl or carbethoxy, with an alcohol of formula HO.CHOH.CH 2 OH or a cyclic ketal thereof, optionally followed by splitting off the ketal group. Intermediates of Formula VI above wherein B is H, cyano, carbamoyl, acetyl, benzoyl, carbethoxy and vinyl are prepared either by esterification of the free acid or transesterification of the methyl ester with the appropriate alcohol HOCH 2 B or in the case of the compound B=carbamoyl by hydrolysis of the compound B=CN. Anilinonicotinic acids and their esters used to prepare intermediates of Formula VI above wherein A is N are prepared either by reaction of an appropriate 2-chloronicotinic acid or ester and an appropriately substituted aniline. Pharmaceutical compositions having antiinflammatory antipyretic and analgesic action in conventional forms for oral, rectal, topical or transcutaneous administration comprise an above novel compound and pharmaceutical carriers or excipients.
[GB1220468A]
Patent IE-830423-L (IE)
Title: Digital network
IPC: H04J/
Filed: 1983-03-01
Abstract: The transit exchange has a signal-controlled oscillator with an output signal which depends on the collectively weighted phase difference between the local exchange clock and the clock of the other exchanges. To avoid phase jumps, a signal corresponding to the phase difference is sampled, the sampled values differentiated, the differentiated values compared with a limit value employing a phase jump when exceeded, and when this value is exceeded a signal with the control signal's highest value but with opposite sign is added to form a compensation signal, this compensation signal being added to the differentiated value, and after possible weighting the differentiated value is summed with corresponding differentiated values from comparison with the phases of other links, and the sum value integrated to obtain a resulting control signal.
[WO8303175A1]
Patent IE-790579-L (IE)
Title: Imidazo-pyrimidines
IPC: C07D239/30
Filed: 1979-08-08
Abstract: {PG,1 Di-substituted 2,3-dihydroimidazo{8 1,2-c{9 pyrimidines, useful as anti-viral agents.
[US4153695A]
Patent IE-32276-L (IE)
Title: Footstep ball bearing
IPC: G01R1/10
Filed: 1968-05-20
Abstract: 1,206,372. Bearings. SIEMENS A.G. 17 May, 1968 [16 June, 1967; 16 Nov., 1967], No. 23727/68. Heading F2A. A footstep ball bearing has a ball 2 disposed between two bearing bushes, one of which, 3, has a concave bearing surface having a radius of curvature greater than that of the ball, and the other 44 having a pyramidal bearing surface. The bushes are of plastics material, and the pyramidal surface is triangular.
Patent IE-870644-L (IE)
Title: Substituted thiazoles and oxazoles
IPC: C07D277/24
Filed: 1987-03-12
Abstract: Thiazoles and oxazoles of the formula <IMAGE> in which A denotes an n-alkylene group which is optionally mono- or disubstituted by methyl or ethyl groups, X denotes an oxygen or sulphur atom, R1 denotes a hydrogen or halogen atom, a trifluoromethyl, alkyl, phenyl or piperidino group or an amino group which is optionally substituted by one or two alkyl groups or an alkanoyl or benzoyl group, R2 denotes a hydrogen atom or an alkyl group, R3 denotes a hydrogen atom or an alkyl group which can be substituted in the 2- or 3-position by a hydroxyl group, or R3 together with R4 denotes an alkoxycarbonylmethylene group or an ethylene group, where the methylene group adjacent to the N or O atom can be replaced by a carbonyl group, R4 denotes a hydrogen atom, an alkyl group which is optionally substituted by a phenyl, carboxyl, alkoxycarbonyl or cyano group or, in the 2- or 3-position, by a hydroxyl group, or an alkenyl group and R5 denotes a hydroxyl, alkoxy, carboxyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl group, an alkoxy group having 1 to 6 carbon atoms which is substituted at the end by a carboxyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl group, an alkoxy group having 2 to 7 carbon atoms which is substituted at the end by a hydroxyl, alkoxy, phenylalkoxy, amino, alkylamino, dialkylamino, pyrrolidino, piperidino or hexamethyleneimino group, or an ethylene group which is optionally substituted by an alkyl group and which is substituted at the end by a carboxyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl group, their optical isomers, their diastereomers and their acid addition salts. The novel lactams of the formula I, their optical isomers and diastereomers are useful intermediates for the preparation of the morpholines of the formula I, in which R3 and R4 together represent an ethylene group. These morpholines and the other compounds of the above formula I (excepting the lactams), their optical isomers and their diastereomers and also their acid addition salts, in particular their physiologically tolerable acid addition salts with inorganic or organic acids, have valuable pharmacological properties, namely an effect on the metabolism, preferably a blood sugar-lowering and body fat-reducing effect, and also a lowering effect on the atherogenic beta -lipoproteins VLDL and LDL. The novel compounds of the above formula I can be prepared by methods which are known per se.
[EP0239815A1]
Patent IE-34221-L (IE)
Title: Urea pellets
IPC: C07C239/00
Filed: 1970-05-22
Abstract: A process is described wherein prilled urea of low biuret content is prepared by crystallizing urea of low biuret content by melting from only 30 to 70 percent of the urea crystals through the application of heat thereto, and forming a heterogeneous mixture of the unmelted crystals in the melted urea. That mixture is then fed to conventional pelleting apparatus.
[US3936499A]
Patent IE-840788-L (IE)
Title: Factor viii, coagulant polypeptides and monoclonal¹antibodies to them
IPC: G01N33/53
Filed: 1984-03-30
Abstract: 1 or more polypeptides (I) exhibit a hand at a pt. corresp. to Mr ca. 92,000 or bands at pts. corresp. to Mr values of ca. 92,000, ca. 80,000 and ca. 79,000; of ca. 92,000, ca. 72,000 and ca. 71,000; or of ca. 92,000, ca. 80,000, ca. 79,000, ca. 72,000 and ca.71,000; when subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Coagulant has a specific conjulant activity over 1800 U/mg, the activity being shown over a continuous period of at least ca. 10 min.; and the coagulant exhibits human factor VIII:C antibody binding capacity. IgG monoclonal antibody is produced by a hybridoma formed by fusion of cells from a mouse myeloma and spleen cells from a mouse previously immunised with human factor VIII:C. Antibody reacts with human factor VIII:C and exhibits one of the following reactions. (a) Reacts with polypeptides of Mr 92,000, Mr 180,000 or greater and Mr 54,000 and does not react with those of Mr 44,000, 71,000, 72,000, 79,000, 80,000; (b) reacts with polypeptides of Mr 92,000, 100,000 or greater and 44,000 and does not react with those of Mr 54,000, 71,000, 72,000, 79,000, 80,000; (c) reacts with polypeptides of Mr 79,000, 80,000 and 100,000 or greater and does not react with those of Mr 44,000, 54,000, 71,000, 72,000, 92,000; (d) reacts with polypeptides of Mr 108,000 or greater but not with those of Mr below 108,000.
Patent IE-800918-L (IE)
Title: Phenylethylamine derivatives
IPC: C07C231/12
Filed: 1980-05-05
Abstract: A derivative of benzimidazole of the general formula I: <IMAGE> I wherein: R1 represents a linear or ramified alkyl radical C1,C2,C3,C4,C5,C6,C7,C8,C9,C10,C11,C12,C13,C14,C15, C16,C17 or C18, a cycloalkyl radical C3,C4,C5,C6,C7 or C8, a linear or ramified alkyl radical C1,C2,C3,C4 or C5 substituted by one or more radicals selected from the group comprising: phenyl, phenoxy, phenylthio, phenylsufinyl radicals; phenyl, phenoxy, phenylthio, phenylsulfinyl radicals substituted by one or more linear or ramified alkyl radicals C1,C2, C3 or C4, by one or more linear or ramified alkoxy radicals C1,C2, C3 or C4, by a methylenedioxy radical, for one or more halogen atoms, such as fluorine, chlorine or bromine; linear or ramified alkylcarboxamido groups C1,C2,C3,C4,C5 or C6 optionally substituted by a phenyl or phenoxy radical; cycloalkylcarboxamido groups C1,C4,C5,C6,C7 or C8, R2 represents hydrogen, one or more linear or ramified alkyl radicals C1,C2,C3 or C4, one or more linear or ramified alkoxy radicals C1,C2,C3 or C4, one or more halogen atoms, such as fluorine, chlorine and bromine, R3 represents hydrogen, one or more linear or ramified alkyl radicals C1,C2,C3 or C4, one or more linear or ramified alkoxy radicals C1,C2,C3 or C4, one or more halogen atoms such as fluorine, chlorine and bromine, one or more nitro groups, as well as esters and salts of such derivatives with non toxical and pharmaceutically acceptable acids.
[US4338330A]
Patent IE-840948-L (IE)
Title: Resilient cellular polymers for absorbing body fluids
IPC: A61L15/00
Filed: 1984-04-17
Abstract: An absorbent, flexible, resilient, cellular polymer is provided which comprises the reaction product of at least one epoxy resin and amine terminated poly(alkylene oxide).
Patent FI-831562-L (FI)
Inventor: REINLE ERWIN
IPC: E04F13/08
Filed: 1983-05-06
Abstract: The outer face of the plate-like coating element comprises a plate (1) with scales (2) separated from each other by blind grooves (3). The plate (1) has flanges (6, 7) on two contiguous edges (4, 5) and notches (10, 11) on complementary edges (8, 9). The grooves (3) extend from the flange (6) on one portion of the height (h) of the plate (1) so that the scales are interconnected at the base thereof by a continuous band (12), projecting on the edge (5) of the plate (1) with a protuberance (13) on the flange (7). The vertical joint may not only be covered in a major portion by two adjacent coating elements, but it may also be almost entirely concealed to sight.
Patent FI-851604-L (FI)
Inventor: DE JONG ROELOF PIETER
IPC: H01P5/107
Filed: 1985-04-23
Abstract: The invention relates to a receiving arrangement 4-1 for SHF signals, comprising a rectangular waveguide filter 5 formed from resonators 10-1 to 10-4 arranged in cascade, a SHF signal arrangement 6 containing a microstrip circuit and a microstrip to waveguide filter transition connection to this circuit.Generally, such a receiving arrangement is not suitable for use in radiators comprising a partly shown polarization converter 3 with two such receiving arrangement 4-1 each receiving one of two mutually orthogonally polarized signals. When the prior art receiving arrangements are used in these radiators, the channel separation is inadequate.According to the invention, an adequate channel separation is obtained by providing the microstrip to waveguide filter transition in the waveguide filter and matching the filter 5 thereto. As a result thereof, the receiving arrangement 4-1 becomes more compact and has a very low reflection and, in addition, it is no longer necessary to adjust the transition to the waveguide filter 5.Preferably, dimensioning is realized by the choice of the size in the axial direction of the end resonator 10-4 and/or the choice of the dimensions of the coupling aperture which connects the end resonator 10-4 to the adjacent resonator 10-3.
Patent IE-781130-L (IE)
Title: Bearing for rotary drill bits
IPC: F16C17/04
Filed: 1978-06-02
Abstract: An unsealed rotary drill of the type comprising a bearing shaft, a roller rotatably mounted on the shaft, cutting inserts carried by the roller, bearing for rotatably supporting the roller on the shaft, and a flushing channel terminating at an end surface of the bearing shaft for conducting cooling air to the bearing. The bearing includes an axial bearing comprising an insert plate formed of sintered hard metal alloy, and a supporting plate formed of a material which is less hard and less wear resistant than the metal alloy. The supporting plate contains a solid lubricant. The supporting plate and the insert plate present opposed bearing surfaces. The insert plate is mounted in the end surface of the bearing shaft such that a rear surface of the insert plate is acted upon by cooling air from the flushing channel.
[SE7706480L]
Patent IE-801206-L (IE)
Title: Ergot peptide derivatives
IPC: A61P25/26
Filed: 1980-06-11
Abstract: A 2-methyl-8 (R) or (S) ergot peptide alkaloid in free base form or in pharmaceutically acceptable acid addition salt form is a useful anti-Parkinson agent, prolactin secretion inhibitor, anti-depressant, vigilance-increasing agent, and anti-migraine agent.
[US4547500A]
Patent IE-851348-L (IE)
Title: Microinductive investigation of earth formations
IPC: G01V3/28
Filed: 1985-05-30
Abstract: A wall-engaging apparatus for microinductively investigating a characteristic of earth formation traversed by a borehole includes an antenna set mounted in a longitudinally elongated body adapted for a sliding engagement with the wall of the borehole. The antenna set includes a first antenna element, and second and third antenna elements, having locations and orientations to place them in electromagnetic symmetry relative to the first antenna element. Means are included for differentially coupling the second and third antenna elements. Either the first antenna element or the differentially-coupled second and third antenna elements may be energized to function as a transmitter, while the other functions as a receiver of signals indicative of the characteristic. Alternative variations include a conductive body for focussing electromagnetic energy, a coductive backplane which enables half-loop antenna elements and an electroquasistatic shield which improve the performance of the antenna set.
[EP0163574A2]
Patent IE-36783-L (IE)
Title: Making moulds
IPC: B22C9/03
Filed: 1972-10-18
Abstract: 1377836 Foundry moulding processes and apparatus AKITA KK 17 Oct 1972 [18 Feb 1972] 47729/72 Heading B3F A method of making a foundry mould comprises applying to a pattern 1 a layer of parting agent 22, 23 (e.g. epoxy resin powder applied by electrostatic spraying), applying to the parting agent a layer 24, 25 of shield film (e.g. by painting on and drying a synthetic resin composition), moving flasks 7, 8 adjacent the pattern 1, compacting sand 26, 27behind the film-layers 24, 25 (e.g. by a vibrator 21), applying suction to the compacted sand 26, 27 to bring the film layers 24, 25 into intimate contact with the compacted sand 26, 27 and separating the pattern 1 from the flasks 7, 8. The flasks 7, 8 have filter vent plates 13, 14, 15, 16 behind which are spaces 9, 10 connected by ducts 17, 18 to apparatus (not shown) for applying suction to the sand 26, 27. During suction the flask-filling apertures 19, 20 are covered by lids of synthetic resin film, 28, 29. In order readily to separate the pattern 1 from the formed mould, ducts 4, 5 are formed in the pattern 1 into which compressed air is blown to form the film layers 24, 25 away from the pattern 1 after moulding.
[GB1377836A]